Catalyst Calendar

Thu, Aug 20, 2026

1 updates

8:00 AM

Adagene to Participate in Three Upcoming Investor Conferences

SAN DIEGO and SUZHOU, China, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (Nasdaq: ADAG) a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced that senior management will participate in three upcoming

adagene.com

Wed, Aug 12, 2026

1 updates

ADAG

7:30 AM

Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates

Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established Data reported at AACR from triple combination therapy in 1L hepatocellular

Presentation / Abstract • Phase 1/2AACR presentation Wed, Apr 1, 2026adagene.com